Skip to main content
Top
Published in: Clinical and Translational Oncology 1/2014

01-01-2014 | Research Article

Effectiveness of a protocolized system to alert pulmonologists of lung cancer radiological suspicion

Authors: V. Leiro-Fernández, M. Botana-Rial, A. Tilve-Gómez, C. Represas-Represas, A. Pallarés-Sanmartín, A. Fernández-Villar

Published in: Clinical and Translational Oncology | Issue 1/2014

Login to get access

Abstract

Purpose

When lung cancer (LC) is suspected in chest radiography, an adequate interpretation and management by experts would improve the selection, the access to rapid diagnostic units, the diagnostic effectiveness and prevent the loss of patients with suspected LC. To ensure this, we planned a system for alerting pulmonologists by radiologists to radiological suspicion of LC.

Methods

This system consists of an alert from radiologists to pulmonologists through a specific email. The pulmonologists alerted has to contact the study doctor petitioner who must refer the patient for study to the Lung Cancer Rapid Diagnostic Unit (LCRDU). We have prospectively analyzed all patients studied in a 2-year period including clinical variables, time invested in the different diagnostic steps and the degree of collaboration and satisfaction among the involved professionals.

Results

Of 118 alerts received, 84 (71 %) were studied in our LCRDU. The median of days until petitioner contact, patient consulted at LCRDU and to obtain a diagnosis was 1 (IQR 0–1.5), 2 (IQR 1–5) and 13 (IQR 7.5–30), respectively. In 45 cases (53 %), the suspicion of malignancy was confirmed (LC 84.4 % and metastasic 10.1 %). After staging was complete, 33 % of non-small cell lung cancer was potentially resectable (clinical TNM stage I–II). The level of satisfaction was high so that only one of the petitioner’s studies chose other diagnostic pathways.

Conclusion

This strategy for radiological suspicion of LC ensures the communication between general practitioners, radiologists and pulmonologist improving the LC diagnostic effectiveness. This system can be easily implemented in health care systems.
Literature
1.
go back to reference Olsson JK, Schultz EM, Gould MK. Timeless of care in patients with lung cancer: a systematic review. Thorax. 2009;64:749–56.PubMedCrossRef Olsson JK, Schultz EM, Gould MK. Timeless of care in patients with lung cancer: a systematic review. Thorax. 2009;64:749–56.PubMedCrossRef
3.
go back to reference Barret J, Hamilton W. Pathways to the diagnosis of lung cancer in the UK: a cohort study. BMC Fam Pract. 2008;9:31.CrossRef Barret J, Hamilton W. Pathways to the diagnosis of lung cancer in the UK: a cohort study. BMC Fam Pract. 2008;9:31.CrossRef
4.
go back to reference Turkington PM, Kennan N, Greenstone MA. Misinterpretation of the chest x ray as a factor in the delayed diagnosis of lung cancer. Postgrad Med J. 2002;78:158–60.PubMedCrossRef Turkington PM, Kennan N, Greenstone MA. Misinterpretation of the chest x ray as a factor in the delayed diagnosis of lung cancer. Postgrad Med J. 2002;78:158–60.PubMedCrossRef
5.
go back to reference Rami-Porta R, Crowley JJ, Goldstraw P. The revised TNM staging system for lung cancer. Ann Thoracic Cardiovasc Surg. 2009;15:4–9. Rami-Porta R, Crowley JJ, Goldstraw P. The revised TNM staging system for lung cancer. Ann Thoracic Cardiovasc Surg. 2009;15:4–9.
6.
go back to reference British Thoracic Society. BTS recomemendations to respiratory physicians for organising the care of patients with lung cancer. Thorax. 1998;53:S1–8. British Thoracic Society. BTS recomemendations to respiratory physicians for organising the care of patients with lung cancer. Thorax. 1998;53:S1–8.
7.
go back to reference Reifel J. Lung Cancer. In: Asch S, Kerr E, Hamilton E, editors. Quality of care for oncologic conditions and HIV: a review of the literature and quality indicators. RAND Corporation; 2000. p.113–72. Reifel J. Lung Cancer. In: Asch S, Kerr E, Hamilton E, editors. Quality of care for oncologic conditions and HIV: a review of the literature and quality indicators. RAND Corporation; 2000. p.113–72.
8.
go back to reference Alberts WM, Bepler G, Hazeton T, Ruckdeschel JC, Williams JH. American collegue of chest physiscians practice organization. Chest. 2003;23:S332–7.CrossRef Alberts WM, Bepler G, Hazeton T, Ruckdeschel JC, Williams JH. American collegue of chest physiscians practice organization. Chest. 2003;23:S332–7.CrossRef
9.
go back to reference Brocken P, Kiers BA, Looijen-Salomom MG, Dekhuijzen PN, Smits-van der Graaf C, Peters-Bax L, et al. Timeliness of lung cancer diagnosis and treatment in a rapid outpatient diagnostic program with combined (18)FDG-PET and contrast enhanced CT scanning. Lung Cancer. 2012;75:336–41.PubMedCrossRef Brocken P, Kiers BA, Looijen-Salomom MG, Dekhuijzen PN, Smits-van der Graaf C, Peters-Bax L, et al. Timeliness of lung cancer diagnosis and treatment in a rapid outpatient diagnostic program with combined (18)FDG-PET and contrast enhanced CT scanning. Lung Cancer. 2012;75:336–41.PubMedCrossRef
10.
go back to reference Bjerager M, Palshof T, Dahl R, Vedsted P, Olesen F. Delay in diagnosis of lung cancer in general practice. Br J Gen Pract. 2006;56:863–8.PubMedCentralPubMed Bjerager M, Palshof T, Dahl R, Vedsted P, Olesen F. Delay in diagnosis of lung cancer in general practice. Br J Gen Pract. 2006;56:863–8.PubMedCentralPubMed
11.
go back to reference Salomaa ER, Sällinen S, Hiekkanen H, Lippo K. Delays in the diagnosis and treatment of lung cancer. Chest. 2005;128:2282–8.PubMedCrossRef Salomaa ER, Sällinen S, Hiekkanen H, Lippo K. Delays in the diagnosis and treatment of lung cancer. Chest. 2005;128:2282–8.PubMedCrossRef
12.
go back to reference Abal Arca JA, Ramos MA, De la Infanta RG, López CP, Pérez LG, López JL. Lung cancer diagnosis: hospitalization costs. Arch Bronconeumol. 2006;42:569–74.CrossRef Abal Arca JA, Ramos MA, De la Infanta RG, López CP, Pérez LG, López JL. Lung cancer diagnosis: hospitalization costs. Arch Bronconeumol. 2006;42:569–74.CrossRef
Metadata
Title
Effectiveness of a protocolized system to alert pulmonologists of lung cancer radiological suspicion
Authors
V. Leiro-Fernández
M. Botana-Rial
A. Tilve-Gómez
C. Represas-Represas
A. Pallarés-Sanmartín
A. Fernández-Villar
Publication date
01-01-2014
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 1/2014
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-013-1042-0

Other articles of this Issue 1/2014

Clinical and Translational Oncology 1/2014 Go to the issue

Acknowledgement to Referees

Acknowledgement to Referees 2013

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine